Maria J. Rosales

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Drivers of Mosquito Microbiome Composition: Effects of Species, Locality, Season, and Plasmodium Infection.

Drivers of Mosquito Microbiome Composition: Effects of Species, Locality, Season, and Plasmodium Infection.

Journal: Microbial ecology

Published: March 12, 2026

Correction: Avian Plasmodium in invasive and native mosquitoes from southern Spain.

Correction: Avian Plasmodium in invasive and native mosquitoes from southern Spain.

Journal: Parasites & vectors

Published: March 16, 2024

Avian Plasmodium in invasive and native mosquitoes from southern Spain.

Avian Plasmodium in invasive and native mosquitoes from southern Spain.

Journal: Parasites & vectors

Published: November 08, 2023

Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase.

Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase.

Journal: Pharmaceutics

Published: November 03, 2022

Antibacterial Activity of Two Zn-MOFs Containing a Tricarboxylate Linker.

Antibacterial Activity of Two Zn-MOFs Containing a Tricarboxylate Linker.

Journal: Nanomaterials (Basel, Switzerland)

Published: October 17, 2022

An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment.

An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment.

Journal: ACS infectious diseases

Published: June 02, 2022

Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery.

Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery.

Journal: Acta tropica

Published: May 15, 2022

5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii.

5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii.

Journal: Acta tropica

Published: March 16, 2022

Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and In Vivo Studies.

Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and In Vivo Studies.

Journal: ACS infectious diseases

Published: April 19, 2021

Library of Selenocyanate and Diselenide Derivatives as In Vivo Antichagasic Compounds Targeting Trypanosoma cruzi Mitochondrion.

Library of Selenocyanate and Diselenide Derivatives as In Vivo Antichagasic Compounds Targeting Trypanosoma cruzi Mitochondrion.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 24, 2021

In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent Necrosis.

In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent Necrosis.

Journal: Journal of natural products

Published: November 30, 2020

Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition.

Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition.

Journal: Parasitology research

Published: December 18, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026